Celiac Disease Vaccine Candidate Granted FDA Fast Track — Precision Vaccinations
ImmusanT cans phase 2 celiac trial after interim efficacy review | Fierce Biotech
A Participant's Perspective on the Failure of the Nexvax2 "Celiac Disease Vaccine" Clinical Trial - Celiac.com
ImmusanT Announces Completion of Phase 1b Clinical Trial for Celiac Disease Treatment - Drug Discovery and Development
Celiac Vaccine Trial Participant Shares Experience With Nexvax2 - Gluten-Free Living
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies - ScienceDirect
Epitope-specific immunotherapy: a vaccine for coeliac disease? - The Lancet Gastroenterology & Hepatology
ImmusanT goes on hiring spree ahead of phase 2 celiac vaccine trial | Fierce Biotech
Randomised clinical trial: a placebo‐controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease - Truitt - 2019 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo ...
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease
ImmusanT Announces Completion of Phase 1b Clinical Trial of Nexvax2® for the Treatment of Celiac Disease | Business Wire
Randomised clinical trial: a placebo‐controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease - Truitt - 2019 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Celiac Disease Vaccine Candidate Nexvax2 Shows Promise — Precision Vaccinations
Nexvax2 Setback Only One Aspect of Ongoing Scientific Discovery | BeyondCeliac.org
Discontinuation of the Nexvax2 Phase 2 trial - Coeliac New Zealand
Nexvax2 trial discontinued | BeyondCeliac.org
Frontiers | Vaccine Immunotherapy for Celiac Disease | Medicine
Frontiers | A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease | Immunology
Nexvax2® Research Update - Coeliac New Zealand
Celiac Disease Cure? ImmusanT Tests Nexvax2 in Clinical Trials - Xtalks
Current and emerging therapies for coeliac disease | Nature Reviews Gastroenterology & Hepatology
Celiac disease vaccine clinical trial canceled — here's a local expert's response | PhillyVoice
Celiac Vaccine Clears First Big Clinical Trial - Celiac.com
World's first celiac vaccine gains FDA fast-track designation during Phase 2 trial
ImmusanT Discontinues Phase 2 Clinical Trial for Nexvax2® in Patients With Coeliac Disease - Wesley Medical Research
Startup Pioneers Celiac Disease Remedy
